154 results on '"Christofyllakis, Konstantinos"'
Search Results
2. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
3. Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18F-FDG PET/CT
4. Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report
5. Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.
6. A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity.
7. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study.
8. KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
9. Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [18F]FDG PET/CT
10. Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report.
11. Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
12. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
13. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
14. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
15. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
16. Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper
17. Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
18. Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [ 18 F]FDG PET/CT.
19. Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R) - CHOP
20. Is less always more? Emerging treatment concepts in geriatric hemato-oncology
21. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
22. Hyper N-Glycosylated SEL1L3 As B-Cell Receptor Autoantigen of Primary Vitreoretinal Lymphoma
23. Adjuvant therapy of high-risk malignant melanoma in the post interferon-alpha era: a systematic review and meta-analysis
24. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
25. Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2
26. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
27. Untersuchung des KIR-Status bei Patienten mit Plattenepithelkarzinom im Kopf-Hals-Bereich aus Serumproben
28. Investigation of the KIR-status of patients with head and neck squamous-cell carcinoma in bloodserum
29. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
30. Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
31. Advances in Lymphoma Molecular Diagnostics
32. IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study
33. Influence of Vitamin D on Genome-Wide Expression in Natural Killer Cells
34. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
35. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
36. A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)
37. Monocyte Subpopulations and Their Expression of HLA-DR and CD300e after Allogeneic Stem Cell Transplantation in Patients with or without GvHD
38. Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18 F-FDG PET/CT.
39. Additional file 1 of Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
40. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
41. Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis
42. IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study.
43. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
44. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy
45. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial.
46. Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies
47. WALKING TH E LINE BETWEEN TREATMENT BENEFIT AND TOXICITY IN LIMITED-STAGE DLBCL OF THE ELDERLY: A CASE REPORT
48. FRI0384 IMPACT OF INTERLEUKIN 17 BLOCKING AGENT ON CLINICAL OUTCOME IN SAPHO PATIENTS
49. Reduction of Chemotherapy in Aggressive Non-Hodgkin's Lymphoma with Favorable Prognosis
50. Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.